Multi-omics approach to identify pancreatic cancer biomarkers in liquid biopsies of advanced stage patients by pioneering single cell mass spectrometry of CTCs and (epi)genetics characterization of cfDNA Ghent University
Pancreatic cancer is a deadly disease with surgery the only chance for cure. Surgeons have to evaluate whether patients with advanced pancreatic cancer will benefit from surgery. Current diagnostic tools (imaging and CA19-9), are inadequate, with early recurrence and metastases seen in up to 40% of patients. To address this, a multi-omics approach is proposed to identify PDAC biomarkers in liquid biopsies with higher accuracy, sensitivity, ...